BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8543846)

  • 1. [The clinical significance of the ratio in FSH/LH of human menopausal gonadotropins in a programmed stimulation regimen for IVF-ET].
    Ikenaga H
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Nov; 47(11):1223-9. PubMed ID: 8543846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
    Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
    Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial.
    Pacchiarotti A; Sbracia M; Frega A; Selman H; Rinaldi L; Pacchiarotti A
    Fertil Steril; 2010 Nov; 94(6):2467-9. PubMed ID: 20537626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
    Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. II. Comparison of hMG and recombinant FSH.
    Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
    Int J Fertil Womens Med; 1997; 42(6):431-5. PubMed ID: 9459089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian stimulation with various FSH/LH concentrations in an in vitro fertilization program].
    Diedrich K; Diedrich C; Germer U; Bauer O; al-Hasani S; Krebs D; Kleber E
    Geburtshilfe Frauenheilkd; 1994 Mar; 54(3):167-70. PubMed ID: 8188016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined treatment with a GnRH-analog and gonadotropins in IVF-ET/GIFT patients after previously unsuccessful pure HMG stimulation].
    Urbancsek J; Rabe T; Grunwald K; Thuro H; Runnebaum B
    Zentralbl Gynakol; 1991; 113(10):563-74. PubMed ID: 1927104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes' number and competence.
    Albu D; Albu A
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrafollicular and serum levels of leptin during in vitro fertilization cycles: comparison between the effects of recombinant follicle-stimulating hormones and human menopausal gonadotrophin.
    Almog B; Azem F; Kapustiansky R; Azolai J; Wagman I; Levin I; Hauser R; Pauzner D; Lessing JB; Amit A; Gamzu R
    Gynecol Endocrinol; 2011 Sep; 27(9):666-8. PubMed ID: 20979539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the FSH/LH ratio in ovarian stimulation therapy regime for in vitro fertilization.
    Bhat AM; Feichtinger W; Kemeter P
    Acta Eur Fertil; 1984; 15(6):449-53. PubMed ID: 6443053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled ovarian hyperstimulation for the new reproductive technologies.
    Navot D; Sandler B
    Acta Eur Fertil; 1989; 20(4):217-21. PubMed ID: 2519574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of a combination administration of gonadotropin-releasing hormone agonist and gonadotropins for controlled ovarian hyperstimulation in IVF program.
    Chang YS; Kim SH; Shin CJ; Kim JG; Moon SY; Lee JY
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):337-45. PubMed ID: 2129188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovarian response and induction of ovulation with human menopausal gonadotropin of different ratio of FSH to LH content in women with ovarian insufficiency].
    Koyama T; Kamata S; Kubota T; Ohara M; Ichimura M; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):445-51. PubMed ID: 3131463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
    Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
    Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulation induction for in-vitro-fertilization and embryo transfer applying decapeptyl (DTRP-6 LH/RH) in combination with HMG or FSH.
    Mettler L; Argiriou C; Abd-el Maeboud K; Steinmüller H; Semm K
    Exp Clin Endocrinol; 1988 Mar; 92(3):245-51. PubMed ID: 2978123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LH supplementation in mild stimulations cycles without pituitary suppression: a retrospective analysis.
    Paragona M; Rossini M; Dattilo M; Stamm J
    Gynecol Endocrinol; 2013 Feb; 29(2):101-4. PubMed ID: 23256611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.